SORIATANE Side Effects

5527705-3 | Diabetes Mellitus, Hypertriglyceridaemia, Vision Blurred
on Nov 07, 2007 Female patient from UNITED KINGDOM , 40 years of age, weighting 172.0 lb, was diagnosed with erythrodermic psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, hypertriglyceridaemia, vision blurred. Soriatane dosage: 50 Mg;qd;po ; 25 Mg;qd;po. During the same period patient was treated with SELOZOK (View Selozok Review and Selozok Label ).

5513682-8 | Phlebitis, Pulmonary Embolism
Patient was taking Soriatane (View Usage). Patient had the following side effects: phlebitis, pulmonary embolism (What is pulmonary embolism?) on Oct 09, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 73 years of age, was diagnosed with psoriasis and. Soriatane dosage: ;po. Patient was hospitalized.

5512328-2 | Blood Triglycerides Increased, Condition Aggravated, Dermatitis Exfoliative, Ear Infection, Hypercholesterolaemia
Adverse event was reported on Oct 25, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg Bid Po) was diagnosed with psoriasis and. Location: FRANCE , 49 years of age, After Soriatane was administered, patient had the following side effects: blood triglycerides increased, condition aggravated, dermatitis exfoliative, ear infection (What is ear infection?), hypercholesterolaemia. During the same period patient was treated with TIGASON /00530101/ (ETRETINATE) (Po) (View Tigason /00530101/ (etretinate) Review and Tigason /00530101/ (etretinate) Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

5476815-8 | Deep Vein Thrombosis, Phlebitis, Pulmonary Embolism, Venous Thrombosis Limb
on Sep 25, 2007 Male patient from UNITED STATES , 66 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), phlebitis, pulmonary embolism (What is pulmonary embolism?), venous thrombosis limb. Soriatane dosage: 10 Mg; Qd; Po. Patient was hospitalized.


5473073-5 | Congenital Anomaly, Foetal Malformation, Pregnancy
on Sep 13, 2007 Male patient from UNITED KINGDOM , 17 years of age, was treated with Soriatane (View Usage). Patient had the following side effects: congenital anomaly, foetal malformation, pregnancy (What is pregnancy?). Soriatane dosage: 10 Mg; Qd; Po.

5448340-1 | Condition Aggravated, Presbyopia, Visual Acuity Reduced
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: condition aggravated, presbyopia, visual acuity reduced on Aug 24, 2007 from UNITED KINGDOM Additional patient health information: Female patient , 49 years of age, was diagnosed with psoriasis and. Soriatane dosage: ;po. During the same period patient was treated with MAGNESIUM PIDOLATE (View Magnesium Pidolate Review and Magnesium Pidolate Label ), GINKO BILOBA (View Ginko Biloba Review and Ginko Biloba Label ).

5441509-1 | Pregnancy
Adverse event was reported on Aug 20, 2007 by a Female patient taking Soriatane (View Usage) (Dosage: Po) . Location: UNITED STATES , 29 years of age, Patient experienced the following unwanted or unexpected effects: pregnancy (What is pregnancy?). During the same period patient was treated with BIRTH CONTROL PILLS (View Birth Control Pills Review and Birth Control Pills Label ).

5421244-6 | Abnormal Behaviour, Deep Vein Thrombosis, Dry Skin, Skin Chapped
on Aug 10, 2007 Female patient from UNITED STATES , 81 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: abnormal behaviour, deep vein thrombosis (What is deep vein thrombosis?), dry skin, skin chapped. Soriatane dosage: 10 Mg; Bid; Po. During the same period patient was treated with BUMEX (View Bumex Review and Bumex Label ). Patient was hospitalized.

5415030-0 | Gamma-glutamyltransferase Increased
on Jul 24, 2007 Male patient from FRANCE , 56 years of age, weighting 138.9 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: gamma-glutamyltransferase increased. Soriatane dosage: . During the same period patient was treated with ZYBAN (View Zyban Review and Zyban Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LAMALINE (View Lamaline Review and Lamaline Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), PREVISCAN (View Previscan Review and Previscan Label ).

5410367-3 | Condition Aggravated, Erythrodermic Psoriasis, Hypercholesterolaemia
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, erythrodermic psoriasis, hypercholesterolaemia on Jul 27, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 49 years of age, was diagnosed with psoriasis and. Soriatane dosage: ;po. During the same period patient was treated with TIGASON /00530101/ (ETRETINATE) (;po) (View Tigason /00530101/ (etretinate) Review and Tigason /00530101/ (etretinate) Label ). Patient was hospitalized.

5404112-5 | Phlebitis, Pulmonary Embolism
Adverse event was reported on Jul 23, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: 10 Mg; Qd; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 66 years of age, Patient had the following side effects: phlebitis, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

5402066-9 | Chest Pain, Deep Vein Thrombosis, Pulmonary Embolism, Skin Burning Sensation
on Jul 19, 2007 Male patient from UNITED STATES , 55 years of age, was diagnosed with porokeratosis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: chest pain (What is chest pain?), deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?), skin burning sensation. Soriatane dosage: 25 Mg; Qd; Po. During the same period patient was treated with ENBREL (View Enbrel Review and Enbrel Label ), CELEBREX (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

5399987-2 | Dermatitis Exfoliative, Hypercholesterolaemia
on Jul 27, 2007 Male patient from FRANCE , 49 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, hypercholesterolaemia. Soriatane dosage: . During the same period patient was treated with TIGASON (ETRETINATE) (Oral) (View Tigason (etretinate) Review and Tigason (etretinate) Label ), VITAMIN D2 (ERGOCALCIFEROL) (View Vitamin D2 (ergocalciferol) Review and Vitamin D2 (ergocalciferol) Label ). Patient was hospitalized.

5387212-8 | Pregnancy
Patient was taking Soriatane (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?) on Jun 26, 2007 from FRANCE Additional patient health information: Female patient , 23 years of age, was diagnosed with keratosis follicular and. Soriatane dosage: 10 Mg;qd;po.

5382023-1 | Phlebitis, Pulmonary Embolism
Adverse event was reported on Jun 04, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: 10 Mg Qd Po) was diagnosed with psoriasis and. Location: UNITED STATES , 66 years of age, After Soriatane was administered, patient had the following side effects: phlebitis, pulmonary embolism (What is pulmonary embolism?). Patient was hospitalized.

5374288-7 | Dermatitis Exfoliative, Enanthema, Erythema, Hypersensitivity, Skin Exfoliation, Skin Inflammation
on Dec 20, 2006 Male patient from FRANCE , 29 years of age, was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative, enanthema, erythema, hypersensitivity, skin exfoliation, skin inflammation. Soriatane dosage: . Patient was hospitalized.

5373973-0 | Pregnancy
on Jun 21, 2007 Female patient from UNITED STATES , 29 years of age, was treated with Soriatane (View Usage). Patient had the following side effects: pregnancy (What is pregnancy?). Soriatane dosage: Po. During the same period patient was treated with BIRTH CONTROL PILLS NOS (View Birth Control Pills Nos Review and Birth Control Pills Nos Label ).

5354728-X | Arthralgia, Osteoporosis
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: arthralgia, osteoporosis (What is osteoporosis?) on May 29, 2007 from FRANCE Additional patient health information: Male patient , 55 years of age, weighting 154.3 lb, was diagnosed with psoriasis and. Soriatane dosage: 10 Mg;qd;po.

5352212-0 | Dermatitis Exfoliative
Adverse event was reported on May 25, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: ; Po) was diagnosed with psoriasis and. Location: TUNISIA , 49 years of age, Patient experienced the following unwanted or unexpected effects: dermatitis exfoliative. During the same period patient was treated with ETRETINATE (ETRETINATE) (; Po) (View Etretinate (etretinate) Review and Etretinate (etretinate) Label ), VITAMIN D2 (View Vitamin D2 Review and Vitamin D2 Label ). Patient was hospitalized.

5320916-1 | Interstitial Lung Disease, Pulmonary Fibrosis
on Apr 23, 2007 Female patient from FRANCE , 54 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: interstitial lung disease, pulmonary fibrosis (What is pulmonary fibrosis?). Soriatane dosage: See Image. Patient was hospitalized.

5319914-3 | Scoliosis, Spinal Osteoarthritis
on Apr 25, 2007 Male patient from UNITED STATES , 70 years of age, was diagnosed with pustular psoriasis and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: scoliosis, spinal osteoarthritis. Soriatane dosage: See Image. During the same period patient was treated with INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

5318517-4 | Hypoplastic Left Heart Syndrome, Pregnancy Of Partner
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: hypoplastic left heart syndrome, pregnancy of partner on Apr 23, 2007 from CANADA Additional patient health information: Male patient , weighting 85.00 lb, . Soriatane dosage: Trpl. During the same period patient was treated with TEGISON (Trpl) (View Tegison Review and Tegison Label ).

5318514-9 | Pregnancy Of Partner, Ventricular Hypoplasia
Adverse event was reported on Apr 23, 2007 by a Female patient taking Soriatane (View Usage) (Dosage: Vag) . Location: CANADA , 20 years of age, Patient had the following side effects: pregnancy of partner, ventricular hypoplasia. During the same period patient was treated with TEGISON (Vag) (View Tegison Review and Tegison Label ).

5315272-9 | Pregnancy
on Apr 20, 2007 Female patient from UNITED STATES , 29 years of age, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: pregnancy (What is pregnancy?). Soriatane dosage: Po. During the same period patient was treated with BIRTH CONTROL PILLS NOS (View Birth Control Pills Nos Review and Birth Control Pills Nos Label ).

5308543-3 | Hypoplastic Left Heart Syndrome, Pregnancy Of Partner
on Apr 12, 2007 Female patient from CANADA , 20 years of age, was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: hypoplastic left heart syndrome, pregnancy of partner. Soriatane dosage: Vag. During the same period patient was treated with TEGISON (Vag) (View Tegison Review and Tegison Label ).

5308542-1 | Hypoplastic Left Heart Syndrome, Pregnancy Of Partner
Patient was taking Soriatane (View Usage). Patient had the following side effects: hypoplastic left heart syndrome, pregnancy of partner on Apr 12, 2007 from CANADA Additional patient health information: Male patient , weighting 8.50 lb, . Soriatane dosage: Trpl. During the same period patient was treated with TEGISON (Trpl) (View Tegison Review and Tegison Label ).

5293875-8 | Dyspnoea, Pulmonary Fibrosis, Unevaluable Event
Adverse event was reported on Mar 26, 2007 by a Female patient taking Soriatane (View Usage) (Dosage: ) . Location: FRANCE , 54 years of age, After Soriatane was administered, patient had the following side effects: dyspnoea, pulmonary fibrosis (What is pulmonary fibrosis?), unevaluable event.

5285493-2 | Osteomyelitis
on Mar 22, 2007 Male patient from UNITED STATES , 53 years of age, was diagnosed with pustular psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: osteomyelitis. Soriatane dosage: 25 Mg;qd;po. During the same period patient was treated with DOVONEX (View Dovonex Review and Dovonex Label ), ULTRAVATE (View Ultravate Review and Ultravate Label ), TAZORAC (View Tazorac Review and Tazorac Label ).

5284797-7 | Headache, Muscular Weakness, Myalgia
on May 04, 2006 Female patient from UNITED STATES , 63 years of age, was diagnosed with psoriasis, hypercholesterolaemia and was treated with Soriatane (View Usage). Patient had the following side effects: headache (What is headache?), muscular weakness, myalgia. Soriatane dosage: 25 Mag; Qd; Po. During the same period patient was treated with LIPITOR (See Image) (View Lipitor Review and Lipitor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

5284788-6 | Anaemia, Thrombocytopenia
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: anaemia, thrombocytopenia on May 09, 2006 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with psoriasis and. Soriatane dosage: Po. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PREVACID (View Prevacid Review and Prevacid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), BACTRIM DS (View Bactrim Ds Review and Bactrim Ds Label ).

5284786-2 | Embolic Stroke, Photophobia
Adverse event was reported on Jun 22, 2006 by a Male patient taking Soriatane (View Usage) (Dosage: See Image) was diagnosed with psoriasis and. Location: UNITED STATES , 55 years of age, Patient experienced the following unwanted or unexpected effects: embolic stroke, photophobia. During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ), VITAMINS (View Vitamins Review and Vitamins Label ). Patient was hospitalized.

5284760-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased
on Aug 02, 2006 Female patient from UNITED STATES , 57 years of age, was diagnosed with psoriasis, psoriatic arthropathy and was treated with Soriatane (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Soriatane dosage: 25 Mg;od;po. During the same period patient was treated with ENBREL (See Image) (View Enbrel Review and Enbrel Label ), SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CHONDROITIN W/GLUCOSAMINE (View Chondroitin W/glucosamine Review and Chondroitin W/glucosamine Label ).

5284758-8 | Blood Creatinine Increased, Blood Triglycerides Increased, Blood Urea Increased
on Aug 23, 2006 Female patient from UNITED STATES , 53 years of age, was diagnosed with squamous cell carcinoma and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: blood creatinine increased, blood triglycerides increased, blood urea increased. Soriatane dosage: See Image. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

5283786-6 | Spinal Disorder
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: spinal disorder on Feb 22, 2006 from FRANCE Additional patient health information: Male patient , 57 years of age, weighting 220.5 lb, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg; Po.

5283780-5 | Hepatic Enzyme Increased
Adverse event was reported on Mar 27, 2006 by a Female patient taking Soriatane (View Usage) (Dosage: See Image) was diagnosed with pustular psoriasis and. Location: FRANCE , 50 years of age, Patient had the following side effects: hepatic enzyme increased. During the same period patient was treated with SPASFON (SPASFON) (See Image) (View Spasfon (spasfon) Review and Spasfon (spasfon) Label ), AUGMENTIN (See Image) (View Augmentin Review and Augmentin Label ), SMECTA /00837601/ (SMECTA /00837601/) (3 Df; Qd; Po) (View Smecta /00837601/ (smecta /00837601/) Review and Smecta /00837601/ (smecta /00837601/) Label ), HYDROCORTISONE (Qd; Po) (View Hydrocortisone Review and Hydrocortisone Label ), DAFALGAN (PARACETAMOL) (3000 Mg; Qd; Po) (View Dafalgan (paracetamol) Review and Dafalgan (paracetamol) Label ). Patient was hospitalized.

5283776-3 | Arterial Thrombosis
on Apr 19, 2006 Female patient from FRANCE , 41 years of age, weighting 132.3 lb, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: arterial thrombosis. Soriatane dosage: 25 Mg; Po. During the same period patient was treated with PLAVIX (View Plavix Review and Plavix Label ), ZYBAN (View Zyban Review and Zyban Label ), FONZYLANE (View Fonzylane Review and Fonzylane Label ), ASPEGIC /00002701/ (View Aspegic /00002701/ Review and Aspegic /00002701/ Label ). Patient was hospitalized.

5283645-9 | Photosensitivity Reaction
on Oct 25, 2006 Male patient from UNITED STATES , 64 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: photosensitivity reaction. Soriatane dosage: 25 Mg;bid;po. During the same period patient was treated with DOXEPIN HCL (View Doxepin Hcl Review and Doxepin Hcl Label ), DOVONEX (View Dovonex Review and Dovonex Label ), TRIAMCINOLONE (View Triamcinolone Review and Triamcinolone Label ).

5283637-X | Diabetic Foot Infection, Osteomyelitis
Patient was taking Soriatane (View Usage). Patient had the following side effects: diabetic foot infection, osteomyelitis on Oct 05, 2006 from UNITED STATES Additional patient health information: Male patient , 58 years of age, was diagnosed with psoriasis and. Soriatane dosage: 25 Mg;qd;po. During the same period patient was treated with DOVONEX (View Dovonex Review and Dovonex Label ), CLOBETASOL PROPIONATE (View Clobetasol Propionate Review and Clobetasol Propionate Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ROSIGLITAZONE (View Rosiglitazone Review and Rosiglitazone Label ), METFORMIN (View Metformin Review and Metformin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5278395-9 | Osteomyelitis, Tooth Loss
Adverse event was reported on Mar 15, 2007 by a Male patient taking Soriatane (View Usage) (Dosage: 25 Mg, Qd; Po) was diagnosed with rash pustular and. Location: UNITED STATES , 53 years of age, After Soriatane was administered, patient had the following side effects: osteomyelitis, tooth loss. During the same period patient was treated with DOVONEX (View Dovonex Review and Dovonex Label ), ULTRAVATE (View Ultravate Review and Ultravate Label ), TAZORAC (View Tazorac Review and Tazorac Label ).

5236445-X | Arthralgia, Back Pain, Blood Triglycerides Increased, Musculoskeletal Pain, Myalgia, Pain In Extremity, Pyelonephritis
on Jan 30, 2007 Female patient from FRANCE , 34 years of age, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, back pain (What is back pain?), blood triglycerides increased, musculoskeletal pain, myalgia, pain in extremity, pyelonephritis. Soriatane dosage: 20 Mg; Qd; Po.

5226900-0 | Cholestasis, Diabetes Mellitus Inadequate Control, Lung Disorder, Pruritus, Psoriasis, Rash Erythematous, Renal Failure
on Jan 23, 2007 Female patient from FRANCE , 76 years of age, weighting 154.3 lb, was diagnosed with psoriasis and was treated with Soriatane (View Usage). Patient had the following side effects: cholestasis, diabetes mellitus inadequate control, lung disorder, pruritus, psoriasis, rash erythematous, renal failure. Soriatane dosage: Po. During the same period patient was treated with NOVOMIX 30 (View Novomix 30 Review and Novomix 30 Label ), NOVORAPID (View Novorapid Review and Novorapid Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

5222669-4 | Blood Triglycerides Increased, Musculoskeletal Pain, Myalgia, Pyelonephritis, White Blood Cell Count Increased
Patient was taking Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: blood triglycerides increased, musculoskeletal pain, myalgia, pyelonephritis, white blood cell count increased on Jan 17, 2007 from FRANCE Additional patient health information: Female patient , 34 years of age, was diagnosed with psoriasis and. Soriatane dosage: 20 Mg;qd; Po.

5222283-0 | Arthropathy, Exostosis, Ligament Calcification, Spinal Disorder
Adverse event was reported on Jan 16, 2007 by a Female patient taking Soriatane (View Usage) (Dosage: 10 Mg; Qd; Po) was diagnosed with psoriasis and. Location: UNITED STATES , 76 years of age, Patient experienced the following unwanted or unexpected effects: arthropathy, exostosis, ligament calcification, spinal disorder. During the same period patient was treated with LIPITOR /01326101/ (View Lipitor /01326101/ Review and Lipitor /01326101/ Label ), CAPTOPRIL (View Captopril Review and Captopril Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), MIACALCIN (View Miacalcin Review and Miacalcin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5215418-7 | Acute Pulmonary Oedema, Autoimmune Disorder, Cardiac Valve Disease, Cholestasis, Dermatitis Exfoliative, Fluid Overload, Lymphadenopathy, Myocardial Infarction
on Jan 02, 2007 Female patient from FRANCE , 34 years of age, was diagnosed with psoriasis, tooth abscess and was treated with Soriatane (View Usage). Patient had the following side effects: acute pulmonary oedema, autoimmune disorder, cardiac valve disease, cholestasis, dermatitis exfoliative, fluid overload, lymphadenopathy, myocardial infarction. Soriatane dosage: Po. During the same period patient was treated with RODOGYL (RHODOGIL) (Po) (View Rodogyl (rhodogil) Review and Rodogyl (rhodogil) Label ). Patient was hospitalized.

5196009-3 | Dermatitis Exfoliative, Enanthema, Erythema, Skin Exfoliation, Skin Inflammation
on Dec 20, 2006 Male patient from FRANCE , 29 years of age, was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: dermatitis exfoliative, enanthema, erythema, skin exfoliation, skin inflammation. Soriatane dosage: . Patient was hospitalized.

5186486-6 | Antibody Test Positive, Condition Aggravated, Dna Antibody Positive, Hypothyroidism, Myositis, Psoriasis, Pustular Psoriasis, Rhabdomyolysis, Smooth Muscle Antibody Positive
Patient was taking Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: antibody test positive, condition aggravated, dna antibody positive, hypothyroidism, myositis (What is myositis?), psoriasis, pustular psoriasis, rhabdomyolysis, smooth muscle antibody positive on Dec 01, 2006 from FRANCE Additional patient health information: Male patient , 46 years of age, weighting 198.4 lb, was diagnosed with psoriasis and. Soriatane dosage: 20 Mg; Qd; Po. During the same period patient was treated with RAPTIVA (1 Ml; Qw; Sc) (View Raptiva Review and Raptiva Label ), NEORAL (View Neoral Review and Neoral Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ENBREL (View Enbrel Review and Enbrel Label ). Patient was hospitalized.

5186466-0 | Dermatitis Exfoliative
Adverse event was reported on Dec 04, 2006 by a Male patient taking Soriatane (View Usage) (Dosage: 20 Mg; Qd; Po; See Image) was diagnosed with psoriasis and. Location: FRANCE , 29 years of age, Patient had the following side effects: dermatitis exfoliative. Patient was hospitalized.

5170249-1 | Cerebral Thrombosis, Jugular Vein Thrombosis
on Nov 20, 2006 Female patient from FRANCE , 74 years of age, was diagnosed with pityriasis rubra pilaris and was treated with Soriatane (View Usage). After Soriatane was administered, patient had the following side effects: cerebral thrombosis, jugular vein thrombosis. Soriatane dosage: 20 Mg;qd;po; 30 Mg;qd;po. Patient was hospitalized.

5169517-9 | Accidental Overdose, Hepatotoxicity
on Nov 28, 2006 Male patient from UNITED STATES , 55 years of age, was treated with Soriatane (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, hepatotoxicity. Soriatane dosage: See Image, Po.

5157601-5 | Abortion Induced, Unintended Pregnancy
Patient was taking Soriatane (View Usage). Patient had the following side effects: abortion induced, unintended pregnancy on Nov 06, 2006 from UNITED STATES Additional patient health information: Female patient , 27 years of age, weighting 120.0 lb, was diagnosed with psoriasis and. Soriatane dosage: 35 Mg;qd;po. During the same period patient was treated with ORTHO TRI CYCLEN (View Ortho Tri-cyclen Review and Ortho Tri-cyclen Label ), NEORAL (View Neoral Review and Neoral Label ).